Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection
Month: May 2021
Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.